clorgyline has been researched along with Nervous System Disorders in 5 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Gealageas, R | 1 |
Devineau, A | 1 |
So, PPL | 1 |
Kim, CMJ | 1 |
Surendradoss, J | 1 |
Buchwalder, C | 1 |
Heller, M | 1 |
Goebeler, V | 1 |
Dullaghan, EM | 1 |
Grierson, DS | 1 |
Putnins, EE | 1 |
Ye, N | 1 |
Qin, W | 1 |
Tian, S | 1 |
Xu, Q | 1 |
Wold, EA | 1 |
Zhou, J | 1 |
Zhen, XC | 1 |
Glynn, D | 1 |
Gibson, HE | 1 |
Harte, MK | 1 |
Reim, K | 1 |
Jones, S | 1 |
Reynolds, GP | 1 |
Morton, AJ | 1 |
Benmansour, S | 1 |
Brunswick, DJ | 1 |
Wagner, GC | 1 |
Walsh, SL | 1 |
1 review available for clorgyline and Nervous System Disorders
Article | Year |
---|---|
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidin | 2020 |
4 other studies available for clorgyline and Nervous System Disorders
Article | Year |
---|---|
Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Dogs; Drug Development; Human | 2018 |
Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Antidepressive Agents; Clorgyline; Disease Models, A | 2010 |
The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
Topics: Animals; Autoradiography; Body Temperature; Brain; Clorgyline; Drug Synergism; Iodocyanopindolol; Ma | 1994 |
Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
Topics: Aging; Animals; Clorgyline; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Monoamine Oxidas | 1991 |